Tag: Delix Therapuetics - Psychedelic Alpha

Our 2022 Year in Review is now live.

Read more about the article Delix Therapeutics Partners with the National Institute on Drug Abuse (NIDA) to Advance Research on Non-Hallucinogenic Therapies to Treat Substance Use Disorders

Delix Therapeutics Partners with the National Institute on Drug Abuse (NIDA) to Advance Research on Non-Hallucinogenic Therapies to Treat Substance Use Disorders

Post published:December 7, 2021
Post category:Press Release

Read more about the article Delix Therapeutics Announces Appointment of Dr. John Krystal to Scientific & Strategic Advisory Board

Delix Therapeutics Announces Appointment of Dr. John Krystal to Scientific & Strategic Advisory Board

Post published:October 25, 2021
Post category:Press Release

Read more about the article Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders

Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders

Post published:September 27, 2021
Post category:Press Release

Read more about the article Delix Therapeutics Expands Executive Leadership Team

Delix Therapeutics Expands Executive Leadership Team

Post published:July 6, 2021
Post category:Press Release

Read more about the article Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

Post published:June 4, 2021
Post category:Press Release

Read more about the article Delix Therapeutics Co-Founder Publishes Groundbreaking Study Demonstrating Therapeutic Potential for a Psychedelic Analog—Without Hallucinogenic Effects

Delix Therapeutics Co-Founder Publishes Groundbreaking Study Demonstrating Therapeutic Potential for a Psychedelic Analog—Without Hallucinogenic Effects

Post published:April 28, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.